Vinorelbine Related Clinical Trials
Study of Oral Vinorelbine and Erlotinib in Non-Small Cell Lung Cancer [Completed]
Maintenance Oral Vinorelbine or Observation After Vinorelbine-Docetaxel First Line Chemotherapy in Advanced Breast Ca [Recruiting]
Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer [Terminated]
Study of Combination of Metronomic Oral Vinorelbine and Sorafenib in Patients With Advanced Non-small Cell Lung Cancer [Completed]
Vinorelbine Oral Plus Capecitabine Combination In Metastatic Breast Cancer [Completed]
Afatinib and Vinorelbine in Tumours Known to Overexpress EGFR and/or HER2 [Completed]
Vinorelbine in Mesothelioma [Not yet recruiting]
Vinorelbine/Gemcitabine Versus Vinorelbine/Carboplatin in Advanced Non-small Cell Lung Cancer [Completed]
A Phase I/II Study of ABI-007 (Abraxane®, Nab®-Paclitaxel)and Vinorelbine in Patients With Stage IV (Metastatic) Breast Cancer [Terminated]
Vinorelbine for Children With Progressive or Recurrent Low-grade Gliomas [Active, not recruiting]
A Study Of Everolimus, Trastuzumab And Vinorelbine In HER2-Positive Breast Cancer Brain Metastases [Recruiting]
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors [Active, not recruiting]
Phase II Trial With Metronomic, Capecitabine Plus Oral Vinorelbine for Metastatic Breast Cancer [Recruiting]
Lapatinib + Vinorelbine in ErbB2 Overexpressing, First or Second Line Metastatic Breast Cancer Subjects [Terminated]
Lapatinib in Combination With Oral Vinorelbine for Metastatic Breast Cancer [Recruiting]
Docetaxel (Taxotere), Vinorelbine, and Bevacizumab, as Adjuvant Chemotherapy for Patients With Resected Stage I-III Non-small Cell Lung Cancer [Completed]
Vorinostat in Combination With Vinorelbine in Patients With Advanced Cancer [Terminated]
Study Evaluating Neratinib In Combination With Vinorelbine In Subjects With Advanced Or Metastatic Solid Tumors [Completed]
Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast Cancer [Completed]
Lapatinib+Vinorelbine vs Vinorelbine HER2 Positive Metastatic Breast Cancer Progressed After Lapatinib/Trastuzumab [Recruiting]
BIBW 2992 (Afatinib) and Vinorelbine in Japanese Patients With Advanced Solid Tumours [Completed]
Vinorelbine and Gemcitabine Versus Capecitabine in Pretreated Metastatic Breast Cancer [Completed]
Vinorelbine Metronomic Plus Lapatinib for Overexpressing HER-2 Metastatic Breast Cancer [Withdrawn]
Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors [Completed]
Metronomic Vinorelbine and Bevacizumab in Patients With Non Small Cell Lung Cancer [Recruiting]
Satraplatin and Vinorelbine in Advanced Solid Tumors [Active, not recruiting]
Cetuximab and Vinorelbine in Elderly Subjects With Lung Cancer [Completed]
GEfitinib Plus viNOrelbine in Advanced EGFR Mutated NSCLC. GENOA Trial [Recruiting]
Study With Docetaxel, Carboplatin and Herceptin Versus Vinorelbine and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients [Terminated]
Lapatinib and Vinorelbine in Treating Women With HER2-Overexpressing Locally Advanced or Metastatic Breast Cancer [Completed]
Sequential Versus Simultaneous Use of Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer (MBC) [Completed]
Vinorelbine in Unresectable or Metastatic Esophageal and Gastric Adenocarcinoma [Completed]
Adjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Early Stage Non-Small-Cell Lung Cancer [Terminated]
Phase II Trial of Oral Vinorelbine in Children With Recurrent or Progressive Unresectable Low-Grade Glioma [Recruiting]
Metronomic Oral Vinorelbine in Patients With Metastatic Tumors [Completed]
Vinorelbine Tartrate and Paclitaxel in Treating Older Patients With Advanced Non-Small Cell Lung Cancer [Recruiting]
Bevacizumab in Combination With Vinorelbine and Trastuzumab for HER2-Positive, Metastatic Breast Cancer [Completed]
Trastuzumab in Combination With Vinorelbine or Taxane-Based Chemotherapy in Patients With Metastatic Breast Cancer [Completed]
Effects of Granulocyte Colony-stimulating Factor (G-CSF), Trastuzumab, and Vinorelbine on Immune Cell Function [Terminated]
Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast Cancer [Terminated]
Randomized Trial With Vinorelbine and Gemcitabine Versus Docetaxel and Gemcitabine in Patients With Non-Small Cell Lung Cancer [Completed]
Trial of Docetaxel Versus Vinorelbine as 1st Line Treatment in Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC) [Completed]
Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLC [Completed]
Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast Cancer [Active, not recruiting]
Vinorelbine Metronomic Plus Bevacizumab as Salvage Therapy for Breast Cancer [Terminated]
Docetaxel and Vinorelbine Plus Sargramostim in Metastatic Malignant Melanoma [Completed]
Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer [Completed]
S9804: Vinorelbine in Treating Patients With Stage IV Melanoma [Completed]
Vinorelbine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Treatment and Liver Dysfunction [Completed]
Safety Study of Oral Vinorelbine in Subjects With Non-Hematologic Malignancies [Active, not recruiting]
Vinorelbine and Gemcitabine Combination In Platinum Resistant Recurrent Ovarian Cancer [Completed]
Study Evaluating Neratinib (HKI-272) In Combination With Vinorelbine In Subjects With Solid Tumors And Metastatic Breast Cancer [Active, not recruiting]
Phase IB/II Trial Combining Vinorelbine With Sorafenib as First-Line Treatment in Patients With Metastatic Breast Cancer [Recruiting]
Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer [Active, not recruiting]
Eribulin Versus Vinorelbine in Subjects With Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes [Active, not recruiting]
Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With B-cell Non-Hodgkin's Lymphoma That Has Relapsed Following Peripheral Stem Cell Transplantation [Completed]
Study of Cisplatin/Vinorelbine +/- Cetuximab as First-line Treatment of Advanced Non Small Cell Lung Cancer (FLEX) [Completed]
Pemetrexed-Carboplatin and Gemcitabine-Vinorelbine in Advanced Breast Cancer [Completed]
Dose Finding Study for Combination of Capecitabine, Lapatinib and Vinorelbine in Metastatic Breast Cancer [Terminated]
Study of Gemcitabine and Vinorelbine in Soft Tissue Sarcomas [Completed]
Lapatinib in Combination With Vinorelbine [Completed]
A Trial of Gemcitabine Combined With Vinorelbine as First Line Chemotherapy for Metastatic Breast Cancer [Completed]
Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer [Not yet recruiting]
Bortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Therapy [Completed]
Pemetrexed/Carboplatin vs Vinorelbine/Carboplatin in Patients With Completely Resected Non-small Cell Lung Cancer (NSCLC) [Recruiting]
A Study Evaluating the Efficacy and Safety of Lapatinib + Vinorelbine in ErbB2 Positive Metastatic Breast Cancer Patients [Terminated]
Study of Patient Preference for Oral or Intravenous Vinorelbine in the Treatment of Advanced NSCLC [Recruiting]
Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix [Completed]
Preoperative Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in HER-2 Positive Breast Cancer [Completed]
Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer [Completed]
Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma [Completed]
Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse [Recruiting]
Sorafenib and Vinorelbine in Treating Women With Stage IV Breast Cancer [Completed]
Oral Vinorelbine as Induction Chemotherapy Followed Concomitant Chemoradiotherapy [Completed]
Docetaxel, Vinorelbine and Trastuzumab in the Treatment of Patients With Metastatic Her-2 Positive Breast Cancer [Completed]
Combination of Continuous Low Doses of Vinorelbine, Cyclophosphamide and Interferon Alpha 2b (" Metronomic Chemotherapy ") for Antiangiogenic and Antivascular Effect. Trial With Pharmacodynamic Study in Adult Advanced Neoplasm [Completed]
Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer [Completed]
Phase I Combination With Vinorelbine or Gemcitabine Plus Cisplatin in Locally Advanced or Metastatic NSCLC [Completed]
Safety and Efficacy of INCB007839 With Trastuzumab and Vinorelbine in Patients With Metastatic HER2+ Breast Cancer [Terminated]
Vinorelbine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer [Completed]
Vinorelbine in Treating Older Women With Stage IV Breast Cancer [Completed]
Navelbine And Radiotherapy in Locally Advanced Lung Cancer [Active, not recruiting]
Erlotinib Versus Carboplatin/Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) [Recruiting]
Vinorelbine and Celecoxib in Treating Women With Relapsed or Metastatic Breast Cancer [Terminated]
Temozolomide and Vinorelbine in Treating Patients With Recurrent Brain Metastases [Completed]
Salvage Chemotherapy of Vinorelbine Plus Oxaliplatin in Metastatic Triple-negative Breast Cancer:a Prospective Trial [Recruiting]
PAV-trial: Plerixafor and Chemotherapy With Vinorelbine for Stem Cell Mobilization in Patients With Myeloma [Completed]
Oral Vinorelbine in Combination With Trastuzumab for Metastatic Breast Cancer [Completed]
Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis [Completed]
S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer [Completed]
Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Women With Locally Recurrent or Metastatic Breast Cancer [Completed]
|